Showing results (201-210 of 389) with videos related to

Sort By:
Pageof 39
Oncology and Therapy|March 24, 2021
Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge GapsDyre Kleive, Eline Aas, Jon-Helge Angelsen, et al.
Oncology and Therapy|February 25, 2021
Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and RussiaGordon Cook, Alessandro Corso, Matthew Streetly, et al.
Oncology and Therapy|March 7, 2017
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional ApproachesCelina Ang, Robert G Maki
Oncology and Therapy|March 7, 2017
Identifying and Targeting the Cause of Cancer is Needed to Cure CancerAdouda Adjiri
Oncology and Therapy|March 7, 2017
Liquid Chromatography-Mass Spectrometry/Mass Spectrometry Analysis and Pharmacokinetic Assessment of Ponatinib in Sprague-Dawley RatsPei Wang, Ying Peng, Xiaolan Zhang, et al.
Oncology and Therapy|March 7, 2017
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic MelanomaJordan Amdahl, Lei Chen, Thomas E Delea
Oncology and Therapy|November 15, 2021
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative StudyRebecca Cheng, Kayla Scippa, Frederick L Locke, et al.
Oncology and Therapy|February 14, 2021
Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature ReviewManuel Cobo, Delvys Rodríguez-Abreu, Diego Pérez Parente, et al.
Oncology and Therapy|October 25, 2022
The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysisQiman Zhang, Jin Zheng, Wen Wang, et al.
Oncology and Therapy|September 4, 2025
Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung CancerMyung-Ju Ahn, Byoung Chul Cho, Kadoaki Ohashi, et al.
Pageof 39